Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Growth (Status and Outlook) 2026-2032

June 2026 | 94 pages | ID: GAB331DE97E1EN
LP Information

Abstracts

The global Graft vs. Host Disease (GvHD) Stem Cell Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Graft-versus-host disease (GVHD) is a potentially serious complication of allogeneic stem cell transplantation and reduced-intensity allogeneic stem cell transplantation. In this treatment, a patient?s own damaged or diseased blood-forming stem cells are destroyed. Then they are replaced with healthy stem cells from a donor.

This report presents a comprehensive overview, market shares, and growth opportunities of Graft vs. Host Disease (GvHD) Stem Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Acute Graft-versus-host Disease
• Chronic Graft-versus-host Disease

Segmentation by Application:

• Preclinical
• Clinical Phase 1,2

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Osiris Therapeutics
• Belumosudil
• UChicago Medicine
• Leukemia & Lymphoma Society
• Dana-Farber Cancer Institute
• Mesoblast
• Takeda

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size (2021-2032)
  2.1.2 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Graft vs. Host Disease (GvHD) Stem Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 Graft vs. Host Disease (GvHD) Stem Cell Therapy Segment by Type
  2.2.1 Acute Graft-versus-host Disease
  2.2.2 Chronic Graft-versus-host Disease
  2.2.3 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type
    2.2.3.1 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 Graft vs. Host Disease (GvHD) Stem Cell Therapy Segment by Application
  2.3.1 Preclinical
  2.3.2 Clinical Phase 1,2
  2.3.3 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application
    2.3.3.1 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)

3 GRAFT VS. HOST DISEASE (GVHD) STEM CELL THERAPY MARKET SIZE BY PLAYER

3.1 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Player
  3.1.1 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue by Player (2021-2026)
  3.1.2 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GRAFT VS. HOST DISEASE (GVHD) STEM CELL THERAPY BY REGION

4.1 Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Region (2021-2026)
4.2 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth (2021-2026)
4.4 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth (2021-2026)
4.5 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Country (2021-2026)
5.2 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026)
5.3 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Region (2021-2026)
6.2 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026)
6.3 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Country (2021-2026)
7.2 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026)
7.3 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GRAFT VS. HOST DISEASE (GVHD) STEM CELL THERAPY MARKET FORECAST

10.1 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Region (2027-2032)
  10.1.1 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Region (2027-2032)
  10.1.2 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.1.3 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.1.4 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.1.5 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
10.2 Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Country (2027-2032)
  10.2.1 United States Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.2.2 Canada Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.2.3 Mexico Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.2.4 Brazil Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
10.3 APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Region (2027-2032)
  10.3.1 China Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Forecast
  10.3.2 Japan Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.3.3 Korea Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.3.4 Southeast Asia Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.3.5 India Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.3.6 Australia Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
10.4 Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Country (2027-2032)
  10.4.1 Germany Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.4.2 France Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.4.3 UK Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.4.4 Italy Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.4.5 Russia Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
10.5 Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Region (2027-2032)
  10.5.1 Egypt Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.5.2 South Africa Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.5.3 Israel Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
  10.5.4 Turkey Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast
10.6 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Type (2027-2032)
10.7 Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Graft vs. Host Disease (GvHD) Stem Cell Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Osiris Therapeutics
  11.1.1 Osiris Therapeutics Company Information
  11.1.2 Osiris Therapeutics Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.1.3 Osiris Therapeutics Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Osiris Therapeutics Main Business Overview
  11.1.5 Osiris Therapeutics Latest Developments
11.2 Belumosudil
  11.2.1 Belumosudil Company Information
  11.2.2 Belumosudil Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.2.3 Belumosudil Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Belumosudil Main Business Overview
  11.2.5 Belumosudil Latest Developments
11.3 UChicago Medicine
  11.3.1 UChicago Medicine Company Information
  11.3.2 UChicago Medicine Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.3.3 UChicago Medicine Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 UChicago Medicine Main Business Overview
  11.3.5 UChicago Medicine Latest Developments
11.4 Leukemia & Lymphoma Society
  11.4.1 Leukemia & Lymphoma Society Company Information
  11.4.2 Leukemia & Lymphoma Society Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.4.3 Leukemia & Lymphoma Society Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Leukemia & Lymphoma Society Main Business Overview
  11.4.5 Leukemia & Lymphoma Society Latest Developments
11.5 Dana-Farber Cancer Institute
  11.5.1 Dana-Farber Cancer Institute Company Information
  11.5.2 Dana-Farber Cancer Institute Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.5.3 Dana-Farber Cancer Institute Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Dana-Farber Cancer Institute Main Business Overview
  11.5.5 Dana-Farber Cancer Institute Latest Developments
11.6 Mesoblast
  11.6.1 Mesoblast Company Information
  11.6.2 Mesoblast Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.6.3 Mesoblast Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Mesoblast Main Business Overview
  11.6.5 Mesoblast Latest Developments
11.7 Takeda
  11.7.1 Takeda Company Information
  11.7.2 Takeda Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
  11.7.3 Takeda Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Takeda Main Business Overview
  11.7.5 Takeda Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Graft vs. Host Disease (GvHD) Stem Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acute Graft-versus-host Disease
Table 4. Major Players of Chronic Graft-versus-host Disease
Table 5. Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 8. Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue Market Share by Player (2021-2026)
Table 13. Graft vs. Host Disease (GvHD) Stem Cell Therapy Key Players Head office and Products Offered
Table 14. Graft vs. Host Disease (GvHD) Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Graft vs. Host Disease (GvHD) Stem Cell Therapy
Table 39. Key Market Challenges & Risks of Graft vs. Host Disease (GvHD) Stem Cell Therapy
Table 40. Key Industry Trends of Graft vs. Host Disease (GvHD) Stem Cell Therapy
Table 41. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Osiris Therapeutics Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 46. Osiris Therapeutics Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 47. Osiris Therapeutics Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Osiris Therapeutics Main Business
Table 49. Osiris Therapeutics Latest Developments
Table 50. Belumosudil Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 51. Belumosudil Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 52. Belumosudil Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Belumosudil Main Business
Table 54. Belumosudil Latest Developments
Table 55. UChicago Medicine Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 56. UChicago Medicine Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 57. UChicago Medicine Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. UChicago Medicine Main Business
Table 59. UChicago Medicine Latest Developments
Table 60. Leukemia & Lymphoma Society Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 61. Leukemia & Lymphoma Society Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 62. Leukemia & Lymphoma Society Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Leukemia & Lymphoma Society Main Business
Table 64. Leukemia & Lymphoma Society Latest Developments
Table 65. Dana-Farber Cancer Institute Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 66. Dana-Farber Cancer Institute Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 67. Dana-Farber Cancer Institute Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Dana-Farber Cancer Institute Main Business
Table 69. Dana-Farber Cancer Institute Latest Developments
Table 70. Mesoblast Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 71. Mesoblast Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 72. Mesoblast Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Mesoblast Main Business
Table 74. Mesoblast Latest Developments
Table 75. Takeda Details, Company Type, Graft vs. Host Disease (GvHD) Stem Cell Therapy Area Served and Its Competitors
Table 76. Takeda Graft vs. Host Disease (GvHD) Stem Cell Therapy Product Offered
Table 77. Takeda Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Takeda Main Business
Table 79. Takeda Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Graft vs. Host Disease (GvHD) Stem Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Graft vs. Host Disease (GvHD) Stem Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Graft vs. Host Disease (GvHD) Stem Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. Graft vs. Host Disease (GvHD) Stem Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Graft vs. Host Disease (GvHD) Stem Cell Therapy in Preclinical
Figure 11. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market: Preclinical (2021-2026) & ($ millions)
Figure 12. Graft vs. Host Disease (GvHD) Stem Cell Therapy in Clinical Phase 1,2
Figure 13. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market: Clinical Phase 1,2 (2021-2026) & ($ millions)
Figure 14. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application in 2025
Figure 15. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Revenue Market Share by Player in 2025
Figure 16. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 17. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 18. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 19. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2021-2026 ($ millions)
Figure 21. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Value Market Share by Country in 2025
Figure 22. United States Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Region in 2025
Figure 27. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 28. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 29. China Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. India Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Country in 2025
Figure 36. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 37. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 38. Germany Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. France Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 52. APAC Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 53. Europe Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 55. United States Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 56. Canada Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 57. Mexico Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 58. Brazil Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 59. China Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 60. Japan Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 61. Korea Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. India Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Australia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Germany Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. France Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. UK Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Italy Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Russia Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. Egypt Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. South Africa Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Israel Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Turkey Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Graft vs. Host Disease (GvHD) Stem Cell Therapy Market Size 2027-2032 ($ millions)